By leveraging its resources, global network, and local expertise across the biopharma ecosystem in Asia, Overland is establishing a portfolio of differentiated therapeutic candidates in a few carefully selected therapeutic areas.

Through formative R&D partnerships, Overland plans to move forward the development and commercialization of the most promising advances in medicine.